New York State Common Retirement Fund’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Sell |
182,693
-8,700
| -5% | -$98.1K | ﹤0.01% | 1402 |
|
|
2025
Q1 | $1.93M | Sell |
191,393
-28,400
| -13% | -$287K | ﹤0.01% | 1386 |
|
|
2024
Q4 | $2.6M | Buy |
219,793
+29,000
| +15% | +$343K | ﹤0.01% | 1325 |
|
|
2024
Q3 | $2.2M | Sell |
190,793
-26,200
| -12% | -$302K | ﹤0.01% | 1380 |
|
|
2024
Q2 | $2.29M | Buy |
216,993
+206
| +0.1% | +$2.18K | ﹤0.01% | 1427 |
|
|
2024
Q1 | $2.29M | Sell |
216,787
-51,305
| -19% | -$541K | ﹤0.01% | 1422 |
|
|
2023
Q4 | $3.01M | Sell |
268,092
-64,221
| -19% | -$721K | ﹤0.01% | 1296 |
|
|
2023
Q3 | $3.88M | Buy |
332,313
+9,217
| +3% | +$108K | 0.01% | 1209 |
|
|
2023
Q2 | $3.26M | Buy |
323,096
+310,925
| +2,555% | +$3.13M | ﹤0.01% | 1334 |
|
|
2023
Q1 | $90K | Buy |
+12,171
| New | +$90K | ﹤0.01% | 2841 |
|